Lucid Diagnostics Inc (LUCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,894 | -12,270 | -28,078 | -16,772 | -9,816 |
| Depreciation Amortization | 728 | 24 | 4 | 3 | 3 |
| Accounts receivable | 200 | 111 | -200 | -200 | N/A |
| Accounts payable and accrued liabilities | 916 | 1,958 | -665 | 781 | -517 |
| Other Working Capital | 500 | 2,522 | -2,250 | -460 | -1,058 |
| Other Operating Activity | 5,469 | 1,879 | 13,521 | 8,857 | 5,779 |
| Operating Cash Flow | $-19,081 | $-5,776 | $-17,668 | $-7,791 | $-5,609 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -384 | -148 | -862 | -38 | -10 |
| Net Acquisitions | -2,200 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-2,584 | $-148 | $-862 | $-38 | $-10 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 688 | 187 | 70,000 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 2,075 | 7,739 | 7,739 |
| Financing Cash Flow | $688 | $187 | $72,075 | $7,739 | $7,739 |
| Beginning Cash Position | 53,656 | 53,656 | 111 | 111 | 111 |
| End Cash Position | 32,679 | 47,919 | 53,656 | 21 | 2,231 |
| Net Cash Flow | $-20,977 | $-5,737 | $53,545 | $-90 | $2,120 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,081 | -5,776 | -17,668 | -7,791 | -5,609 |
| Capital Expenditure | -384 | -148 | -862 | -38 | -10 |
| Free Cash Flow | -19,465 | -5,924 | -18,530 | -7,829 | -5,619 |